EuMAR pilot study - for patients

In this section, you will find information about the EuMAR pilot study, the impact it is expected to have, and how you can contribute to it.

What is EuMAR?

EuMAR is a three-year project aiming to create a unique cycle-by-cycle registry of medically assisted reproduction (MAR) treatments in the European Union (EU). It is organised by the European Society of Human Reproduction and Embryology (ESHRE) and co-funded by the EU.

Why is it important?

EuMAR aims to provide patients and clinicians with data on the real chances of achieving a live birth over an entire course of treatment. This means a clearer calculation of the time to birth from the start of treatment, including all the different cycles that a patient may go through. Overall, EuMAR aims to contribute to better patient care.

EuMAR pilot study

The EuMAR registry is being tested in a pilot study from 1 July to 31 December 2024 in some clinics in Germany, Portugal, Slovenia and Estonia. Data of MAR treatments in these countries will be collected in the EuMAR registry in an anonymised manner.

The EuMAR pilot study is a test of the feasibility of sending cycle-by-cycle MAR treatment data by testing different methods of data submission. With the pilot study, we will identify challenges and best practices before the registry is extended to all European countries.

Which data is collected by EuMAR?

Only clinically relevant data for research purposes, monitoring, and quality management is collected. Data on your identity like your name, address or your personal ID will not be collected by EuMAR.



Patients’ health, safety, and wellbeing are at the centre of our project, and it is important that patients are informed of the EuMAR registry and the pilot study. We value your views and experience and we have organised a survey and focus groups for patients’ input into the EuMAR project. Do you want to contribute? Click on the links on this page.